Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

DEFINING CANDIDATE PARKINSON’S DISEASE GENES THROUGH THE ANALYSIS OF GENOME-WIDE HOMOZYGOSITY

Steven J Lubbe, Yvette C. Wong, Bernabe Bustos, Soojin Kim, Jana Vandrovcova, Brendan P Norman, Manuela Tan, David Murphy, Camille B Carroll, Donald Grosset, Mina Ryten, View ORCID ProfileJuan A. Botía, Valentina Escott-Price, Nigel M Williams, Dimitri Krainc, Huw R Morris, for International Parkinson’s Disease Genomics Consortium
doi: https://doi.org/10.1101/2020.11.23.20235671
Steven J Lubbe
1Ken and Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, USA
2Simpson Querrey Center for Neurogenetics, Northwestern University Feinberg School of Medicine, Chicago, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yvette C. Wong
1Ken and Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernabe Bustos
1Ken and Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, USA
2Simpson Querrey Center for Neurogenetics, Northwestern University Feinberg School of Medicine, Chicago, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Soojin Kim
1Ken and Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jana Vandrovcova
3Department of Clinical and Movement Neuroscience, Queen Square Institute of Neurology, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brendan P Norman
3Department of Clinical and Movement Neuroscience, Queen Square Institute of Neurology, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manuela Tan
3Department of Clinical and Movement Neuroscience, Queen Square Institute of Neurology, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Murphy
3Department of Clinical and Movement Neuroscience, Queen Square Institute of Neurology, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Camille B Carroll
4Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donald Grosset
5Department of Neurology, Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mina Ryten
3Department of Clinical and Movement Neuroscience, Queen Square Institute of Neurology, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan A. Botía
3Department of Clinical and Movement Neuroscience, Queen Square Institute of Neurology, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Juan A. Botía
Valentina Escott-Price
6Institute of Psychological Medicine and Clinical Neurosciences, Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Department of Psychological Medicine and Neurology, Cardiff University School of Medicine, Cardiff, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nigel M Williams
6Institute of Psychological Medicine and Clinical Neurosciences, Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Department of Psychological Medicine and Neurology, Cardiff University School of Medicine, Cardiff, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dimitri Krainc
1Ken and Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, USA
2Simpson Querrey Center for Neurogenetics, Northwestern University Feinberg School of Medicine, Chicago, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Huw R Morris
3Department of Clinical and Movement Neuroscience, Queen Square Institute of Neurology, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: h.morris@ucl.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Early-onset Parkinson’s disease (EOPD) can be caused by biallelic mutations in PRKN, DJ1 and PINK1. However, while the identification of novel genes is becoming increasingly challenging, new insights into EOPD genetics have important relevance for understanding the pathways driving disease pathogenesis. Here, using extended runs of homozygosity (ROH) >8Mb as a marker for possible autosomal recessive inheritance, we identified 90 EOPD patients with extended ROH. Investigating rare, damaging homozygous variants to identify candidate genes for EOPD, 81 genes were prioritised. Through the assessment of biallelic (homozygous and compound heterozygous) variant frequencies in cases and controls from three independent cohorts totalling 3,381 PD patients and 2,463 controls, we identified two biallelic MIEF1 variant carriers among EOPD patients. We further investigated the role of disease-associated variants in MIEF1 which encodes for MID51, an outer mitochondrial membrane protein, and found that putative EOPD-associated variants in MID51 preferentially disrupted its oligomerization state. These findings provide further support for the role of mitochondrial dysfunction in the development of PD. Together, we have used genome-wide homozygosity mapping to identify potential EOPD genes, and future studies incorporating expanded datasets and further functional analyses will help to determine their roles in disease aetiology.

Competing Interest Statement

D.K. is the Founder and Scientific Advisory Board Chair of Lysosomal Therapeutics Inc. D.K. serves on the scientific advisory boards of The Silverstein Foundation, Intellia Therapeutics, and Prevail Therapeutics and is a Venture Partner at OrbiMed. All other authors declare that they do not have conflict of interests. H.R.M reports grants from Medical Research Council UK, grants from Wellcome Trust, grants from Parkinson's UK, grants from Ipsen Fund, during the conduct of the study; grants from Motor Neuron Disease Association, grants from Welsh Assembly Government, personal fees from Teva, personal fees from Abbvie, personal fees from Teva, personal fees from UCB, personal fees from Boerhinger-Ingelheim, personal fees from GSK, outside the submitted work.

Funding Statement

D.K. is supported by the Simpson Querrey Center for Neurogenetics. Please https://pdgenetics.org/partners for details regarding funding.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All data access was granted through membership of the International Parkinson's disease Genetics Consortium, the PROBAND/Tracking Parkinson's project, or Parkinson's families project (REC 15/LO/0097), or following application through the relevant bodies (AMP-PD). The respective local ethical committees for medical research approved involvement in genetic studies and all participants gave written informed consent for the datasets top be used.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵7 See https://pdgenetics.org/partners

Data Availability

The data used is available through application from the following sites: IPDGC: https://pdgenetics.org/contact AMP-PD: https://amp-pd.org

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted November 25, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
DEFINING CANDIDATE PARKINSON’S DISEASE GENES THROUGH THE ANALYSIS OF GENOME-WIDE HOMOZYGOSITY
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
DEFINING CANDIDATE PARKINSON’S DISEASE GENES THROUGH THE ANALYSIS OF GENOME-WIDE HOMOZYGOSITY
Steven J Lubbe, Yvette C. Wong, Bernabe Bustos, Soojin Kim, Jana Vandrovcova, Brendan P Norman, Manuela Tan, David Murphy, Camille B Carroll, Donald Grosset, Mina Ryten, Juan A. Botía, Valentina Escott-Price, Nigel M Williams, Dimitri Krainc, Huw R Morris, for International Parkinson’s Disease Genomics Consortium
medRxiv 2020.11.23.20235671; doi: https://doi.org/10.1101/2020.11.23.20235671
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
DEFINING CANDIDATE PARKINSON’S DISEASE GENES THROUGH THE ANALYSIS OF GENOME-WIDE HOMOZYGOSITY
Steven J Lubbe, Yvette C. Wong, Bernabe Bustos, Soojin Kim, Jana Vandrovcova, Brendan P Norman, Manuela Tan, David Murphy, Camille B Carroll, Donald Grosset, Mina Ryten, Juan A. Botía, Valentina Escott-Price, Nigel M Williams, Dimitri Krainc, Huw R Morris, for International Parkinson’s Disease Genomics Consortium
medRxiv 2020.11.23.20235671; doi: https://doi.org/10.1101/2020.11.23.20235671

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Neurology
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (142)
  • Anesthesia (46)
  • Cardiovascular Medicine (415)
  • Dentistry and Oral Medicine (70)
  • Dermatology (48)
  • Emergency Medicine (144)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4861)
  • Forensic Medicine (3)
  • Gastroenterology (183)
  • Genetic and Genomic Medicine (676)
  • Geriatric Medicine (70)
  • Health Economics (192)
  • Health Informatics (630)
  • Health Policy (321)
  • Health Systems and Quality Improvement (206)
  • Hematology (85)
  • HIV/AIDS (156)
  • Infectious Diseases (except HIV/AIDS) (5343)
  • Intensive Care and Critical Care Medicine (331)
  • Medical Education (93)
  • Medical Ethics (24)
  • Nephrology (75)
  • Neurology (686)
  • Nursing (42)
  • Nutrition (115)
  • Obstetrics and Gynecology (126)
  • Occupational and Environmental Health (208)
  • Oncology (440)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (90)
  • Pain Medicine (35)
  • Palliative Medicine (16)
  • Pathology (129)
  • Pediatrics (194)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (781)
  • Public and Global Health (1817)
  • Radiology and Imaging (325)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (62)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (37)